4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0000950170-24-025915
CIK 0001671584other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:12 PM ET
Size
10.3 KB
Accession
0000950170-24-025915
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2024-03-02+5,500→ 33,837 total - Exercise/Conversion
Common Stock
2024-03-03+3,667→ 37,504 total - Exercise/Conversion
Restricted Stock Unit
2024-03-02−5,500→ 11,000 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-03−3,667→ 3,667 total→ Common Stock (3,667 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:12 PM ET
- Size
- 10.3 KB